Gain Therapeutics (GANX) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.19
-0.15
-0.12
-0.08

Details

Expected EPS
-0.16108
Actual EPS
-0.15
Surprise EPS
0.01
Surprise Percent
+6.88%

Description

Gain Therapeutics (GANX) has reported earnings of -0.15 per share for Q4 2025.

0 Comments

Share your thoughts